Importantly, the tumor microenvironment of surgical specimens from CAR T-Cell treated tumors in this trial displayed marked upregulation of PD-L1, IDO, and TGF-β, as well as FoxP3+ Tregs (199). The gene discussed is TGFB1; the disease is neoplasm.